DOLBY LABORATORIES INC
Reported by Ninety One UK Ltd
Reported 315,806 shares, down 14,792 (4.5%) from the prior quarter.
Reported value 6.8%; share count -4.5% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 160588000 |
| 2022-03-31 | 212957000 |
| 2022-06-30 | 190538000 |
| 2022-09-30 | 154494000 |
| 2022-12-31 | 164130638 |
| 2023-03-31 | 192409234 |
| 2023-06-30 | 166313666 |
| 2023-09-30 | 158052921 |
| 2023-12-31 | 221684779 |
| 2024-03-31 | 191401801 |
| 2024-06-30 | 185791419 |
| 2024-09-30 | 168346256 |
| 2024-12-31 | 39825299 |
| 2025-03-31 | 37404222 |
| 2025-06-30 | 31352930 |
| 2025-09-30 | 29725112 |
| 2025-12-31 | 25618189 |
| 2026-03-31 | 21929279 |
| 2026-06-30 | 17382836 |
| 2026-09-30 | 18559919 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Reduced | 315,806 | -14,792 (-4.5%) | 0.04% | $18,559,919 | 2026-10-15 | |
| Q2 2026 | Reduced | 330,598 | -34,525 (-9.5%) | 0.04% | $17,382,836 | 2026-07-16 | |
| Q1 2026 | Reduced | 365,123 | -33,790 (-8.5%) | 0.05% | $21,929,279 | 2026-04-24 | |
| Q4 2025 | Reduced | 398,913 | -11,825 (-2.9%) | 0.05% | $25,618,189 | 2026-01-27 | |
| Q3 2025 | Reduced | 410,738 | -11,467 (-2.7%) | 0.06% | $29,725,112 | 2025-10-21 | |
| Q2 2025 | Reduced | 422,205 | -43,543 (-9.3%) | 0.07% | $31,352,930 | 2025-07-18 | |
| Q1 2025 | Reduced | 465,748 | -44,179 (-8.7%) | 0.1% | $37,404,222 | 2025-04-30 | |
| Q4 2024 | Reduced | 509,927 | -1,689,815 (-76.8%) | 0.11% | $39,825,299 | 2025-01-27 | |
| Q3 2024 | Reduced | 2,199,742 | -145,221 (-6.2%) | 0.45% | $168,346,256 | 2024-11-12 | |
| Q2 2024 | Added | 2,344,963 | +60,114 (2.6%) | 0.51% | $185,791,419 | 2024-07-22 | |
| Q1 2024 | Reduced | 2,284,849 | -287,497 (-11.2%) | 0.54% | $191,401,801 | 2024-04-25 | |
| Q4 2023 | Added | 2,572,346 | +578,239 (29.0%) | 0.66% | $221,684,779 | 2024-01-31 | |
| Q3 2023 | Added | 1,994,107 | +6,611 (0.3%) | 0.5% | $158,052,921 | 2023-10-10 | |
| Q2 2023 | Reduced | 1,987,496 | -265,012 (-11.8%) | 0.49% | $166,313,666 | 2023-07-19 | |
| Q1 2023 | Reduced | 2,252,508 | -74,266 (-3.2%) | 0.6% | $192,409,234 | 2023-04-28 | |
| Q4 2022 | Reduced | 2,326,774 | -44,591 (-1.9%) | 0.53% | $164,130,638 | 2023-02-07 | |
| Q3 2022 | Reduced | 2,371,365 | -291,273 (-10.9%) | 0.51% | $154,494,000 | 2022-11-14 | |
| Q2 2022 | Reduced | 2,662,638 | -59,896 (-2.2%) | 0.57% | $190,538,000 | 2022-08-15 | |
| Q1 2022 | Added | 2,722,534 | +1,036,041 (61.4%) | 0.54% | $212,957,000 | 2022-05-26 | |
| Q4 2021 | Added | 1,686,493 | +1,483,012 (728.8%) | 0.38% | $160,588,000 | 2022-02-11 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
222 managers reported DOLBY LABORATORIES INC for Q3 2026 so far.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| THE BANK OF NEW YORK MELLON CORPORATION | Added | 5,118,575 | +301,359 | 0.05% | $300,818,670 | 54 qtrs |
| DIMENSIONAL FUND ADVISORS LP | Added | 1,960,467 | +402,298 | 0.02% | $115,211,491 | 54 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 1,856,036 | +13,833 | < 0.01% | $109,095,720 | 54 qtrs |
| BANK OF MONTREAL | Added | 1,743,713 | +286,844 | 0.03% | $102,478,012 | 49 qtrs |
| ACADIAN ASSET MANAGEMENT LLC | Reduced | 1,146,044 | -751,553 | 0.08% | $67,341,000 | 29 qtrs |
| MACKENZIE FINANCIAL CORP | Reduced | 385,721 | -27,695 | 0.02% | $22,668,823 | 35 qtrs |
| Robeco Institutional Asset Management B V | Reduced | 362,743 | -64,948 | 0.03% | $21,318,406 | 15 qtrs |
| Ninety One UK Ltd This report | Reduced | 315,806 | -14,792 | 0.04% | $18,559,919 | 21 qtrs |
| Creative Planning | Added | 315,018 | +135,297 | 0.01% | $18,513,603 | 13 qtrs |
| Squarepoint Ops LLC | Reduced | 270,780 | -64,193 | 0.02% | $15,913,741 | 9 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- October 15, 2026
- Filing type
- 13F-HR
- Position type
- Common Stock
Voting authority reported
- Sole
- 315,806
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.